Allergan, Inc.
Validity of Allergan Patents Acknowledged by Jan Marini in Settlement of Allergan's Patent Infringement Suit Against Jan Marini Skin Research, Inc.
Published in Drug Law Weekly, August 5th, 2008
Allergan, Inc. (NYSE:AGN) announced that it has agreed to dismiss its legal action against Jan Marini Skin Research, Inc. ("Jan Marini"), one of the defendants in Allergan's patent infringement lawsuit pending in the United States District Court for the Central District of California. The dismissal is based on Jan Marini acknowledging the validity of Allergan's relevant patents covering the use of certain drug substances, such as prostaglandin analogs, to promote eyelash enhancement and also agreeing to cease its distribution of eyelash products containing these ingredients in the United States and other countries worldwide where Allergan owns related patents.
As...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-08-05)
More Articles from Drug Law Weekly
- AIDS Healthcare Foundation
AHF Chart Shows How Senate Global AIDS Bill Will Save Five to Seven Million Lives - AIDS Healthcare Foundation
AHF Treatment Proposal Accepted by US Senate: Global AIDS Bill Will Save 5 Million Lives - Alpha Software
Alpha Software Signs Former Accenture Executive as Chief Security Evangelist - Burg Simpson Eldredge Hersh & Jardine, P.C.
Jury Award to Englewood Company to Total More Than $1 Million for Breach of Fiduciary Duties in Shareholder Class Action Case - California Pharmacists Association
Pharmacy Cries Foul as Electronic Data Systems Details Its Three Month Medi-Cal Back Payment Timeline for Pharmacy Medi-Cal Providers - California Pharmacists Association
Pharmacy Shocked as Ninth Circuit Court of Appeals Overturns Temporary Restraining Order on Ten Percent Medi-Cal Cuts to Pharmacy - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
